Registered Tanzania · TMDA

SAFENBEN 10

Fenbendazole Oral Suspension 10% 10 %w/v

TAN 26 VM 0353 Oral Suspension 100 antiparasitic products, insecticides and repellents INN generic

What it does

Fenbendazole is a medication used to treat infections caused by certain parasites in animals. It helps eliminate worms and other parasites from the body.

Commonly used for: worm infections (parasitic infections)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
TAN 26 VM 0353
Registration date
2026-06-26
Expiry date
2031-06-25
Status
Registered/Compliant
Active ingredient
Fenbendazole Oral Suspension 10% 10 %w/v
Dosage form
Oral Suspension
Strength
100
Pack size
-
Therapeutic class
-
ATC class (WHO)
P02CA - Benzimidazole derivatives
RxNorm RxCUI
4325
Country of origin
CHINA
Manufacturer location
189 Tai Hang Nan Da Jie, Yu Hua Qu, Shi Jia Zhuang Shi, He Bei Sheng, China, 050036

Source: Tanzania Medicines and Medical Devices Authority · fetched 2026-07-06 03:14:20 · updated 2026-09-14 03:00:45

Disclaimer: This information is sourced from Tanzania Medicines and Medical Devices Authority (Tanzania). Always consult a qualified healthcare professional before using any medication.

About this medicine

Fenbendazole is a medication used to treat infections caused by certain parasites in animals. It helps eliminate worms and other parasites from the body.

What it treats

  • worm infections (parasitic infections)

How it works

Fenbendazole works by preventing parasites from absorbing sugar, which ultimately kills them and helps clear the infection.

Who it's for

This medication is primarily for animals but can be used in specific cases for humans under guidance.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: fenbendazole

BNF-referenced

Fenbendazole is a broad-spectrum anthelmintic agent primarily used in veterinary medicine. It is effective against a variety of intestinal parasites, including nematodes and some cestodes. Its pharmacological activity stems from its ability to disrupt the microtubule structure in parasites, which is critical for their cellular functions, thereby leading to their death. Fenbendazole is poorly absorbed from the gastrointestinal tract, making it particularly effective for targeting parasites residing in the intestinal lumen.

Indications

  • Intestinal nematodes
  • Cestodes
  • Helminth infections in veterinary practice

Dosage

Children: Refer to the BNF for Children for appropriate dosing recommendations for paediatric patients.

Adults: Refer to the BNF for specific dosing guidelines, as adult doses may vary depending on the type of infection being treated.

Mechanism of action

Fenbendazole exerts its antiparasitic effects by binding to beta-tubulin in parasites, leading to microtubule destabilization and inhibiting tubulin polymerization. This process disrupts cellular functions, including glucose uptake and energy management, particularly in the anterior intestine, where it is most effective due to its poor absorption following oral administration.

Pharmacodynamics

The primary pharmacodynamic action of fenbendazole involves its ability to alter the structure and function of microtubules in parasitic cells. By inhibiting the polymerization of tubulin, fenbendazole interferes with various cellular processes, including mitosis and the transport of secretory vesicles. This ultimately results in the death of the parasites, as they are unable to maintain essential cellular functions.

Pharmacokinetics

Fenbendazole has low oral bioavailability due to poor absorption from the gastrointestinal tract. It undergoes hepatic metabolism and is excreted primarily in the faeces. The duration of action is affected by the persistence of the drug in the intestinal lumen, where it maintains its anthelmintic effects.

Pregnancy

Fenbendazole is not recommended during pregnancy due to potential risks to the developing fetus.

Breast-feeding

It is not known whether fenbendazole is excreted in human milk. Caution is advised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • {'formulation': 'Powder for oral suspension', 'strength': 'Various strengths available'}
  • {'formulation': 'Tablets', 'strength': 'Various strengths available'}

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: fenbendazole

PubChem CID 3334

Molecular formula: C15H13N3O2S

Mechanism of action

Due to its poor absorption by oral administration, fenbendazole is particularly effective for targeting intestinal parasites. It exerts its antiparasitic effects primarily in the anterior intestine by depolymerizing microtubules, inhibiting intestinal secretory vesicle transport. When fenbendazole binds to beta-tubulin in parasites, it causes microtubule destabilization and hinders tubulin polymerization. This destabilization disrupts cellular function, such as glucose uptake, and thus affects the energy management of parasites.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.